Association between switching of primary outcomes and reported trial findings among randomized drug trials from China

Journal of Clinical Epidemiology - Tập 132 - Trang 10-17 - 2021
Yuanxi Jia1, Doudou Huang1, Jiajun Wen1, Jun Liang2, Riaz Qureshi1, Yehua Wang1, Lori Rosman3, Qingkun Chen4, Karen A. Robinson5, Joel J. Gagnier6, David D. Celentano1, Stephan Ehrhardt1
1Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD, USA
2Blood Station, Tongzhou, Beijing, China
3Welch Medical Library, The Johns Hopkins University, Baltimore, MD, USA
4Institute of Information & Medical Library, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
5School of Medicine, The Johns Hopkins University, Baltimore, MD, USA
6Michigan Medicine, School of Public Health, University of Michigan, Ann Arbor, MI, USA

Tài liệu tham khảo

Stanley, 2007, Design of randomized controlled trials, Circulation, 115, 1164, 10.1161/CIRCULATIONAHA.105.594945 Zarin, 2007, Issues in the registration of clinical trials, JAMA, 297, 2112, 10.1001/jama.297.19.2112 Ramagopalan, 2014, Prevalence of primary outcome changes in clinical trials registered on ClinicalTrials. gov: a cross-sectional study, F1000Res, 3, 77, 10.12688/f1000research.3784.1 Dwan, 2013, Systematic review of the empirical evidence of study publication bias and outcome reporting bias—an updated review, PLoS One, 8, e66844, 10.1371/journal.pone.0066844 Jones, 2015, Comparison of registered and published outcomes in randomized controlled trials: a systematic review, BMC Med, 13, 282, 10.1186/s12916-015-0520-3 Jones, 2018, Primary outcome switching among drug trials with and without principal investigator financial ties to industry: a cross-sectional study, BMJ Open, 8, e019831, 10.1136/bmjopen-2017-019831 Ramagopalan, 2015, Funding source and primary outcome changes in clinical trials registered on ClinicalTrials. gov are associated with the reporting of a statistically significant primary outcome: a cross-sectional study, F1000Res, 4, 80, 10.12688/f1000research.6312.1 Pocock, 2016, The primary outcome is positive—is that good enough?, N Engl J Med, 375, 971, 10.1056/NEJMra1601511 Altman, 2017, Harms of outcome switching in reports of randomised trials: CONSORT perspective, BMJ, 356, j396, 10.1136/bmj.j396 DeAngelis, 2005, Clinical trial registration: a statement from the international committee of medical journal Editors, Arch Dermatol, 141, 76, 10.1001/archderm.141.1.76 Dickersin, 2003, Registering clinical trials, JAMA, 290, 516, 10.1001/jama.290.4.516 Zarin, 2017, Update on trial registration 11 years after the ICMJE policy was established, N Engl J Med, 376, 383, 10.1056/NEJMsr1601330 Viergever, 2015, Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013, BMJ Open, 5, e008932, 10.1136/bmjopen-2015-008932 Xu, 2020, Characteristics and trends of clinical studies primarily sponsored by China in WHO primary registries between 2009 and 2018: a cross-sectional survey, BMJ open, 10, 10.1136/bmjopen-2020-037262 Von Elm, 2007, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Ann Intern Med, 147, 573, 10.7326/0003-4819-147-8-200710160-00010 Jia, 2020, Assessment of language and indexing biases among Chinese-sponsored randomized clinical trials, JAMA Netw Open, 3, e205894, 10.1001/jamanetworkopen.2020.5894 Hartung, 2014, Reporting discrepancies between the ClinicalTrials. gov results database and peer-reviewed publications, Ann Intern Med, 160, 477, 10.7326/M13-0480 Xia, 2008, Five large Chinese biomedical bibliographic databases: accessibility and coverage, Health Inf Libraries J, 25, 55, 10.1111/j.1471-1842.2007.00734.x Saldanha, 2014, Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability, PLoS One, 9, e109400, 10.1371/journal.pone.0109400 Easterbrook, 1991, Publication bias in clinical research, Lancet, 337, 867, 10.1016/0140-6736(91)90201-Y Decullier, 2005, Fate of biomedical research protocols and publication bias in France: retrospective cohort study, BMJ, 331, 19, 10.1136/bmj.38488.385995.8F Chan, 2004, Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles, JAMA, 291, 2457, 10.1001/jama.291.20.2457 Chan, 2004, Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research, CMAJ, 171, 735, 10.1503/cmaj.1041086 Hahn, 2002, Investigation of within-study selective reporting in clinical research: follow-up of applications submitted to a local research ethics committee, J Eval Clin Pract, 8, 353, 10.1046/j.1365-2753.2002.00314.x von Elm, 2008, Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee, Swiss Med Wkly, 138, 197 Krleža-Jerić, 2005, Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1), BMJ, 330, 956, 10.1136/bmj.330.7497.956 Zhao, 2010, The status of registrations, ethical reviews and informed consent forms in RCTs of high impact factor Chinese medical journals, Chin J Evid-Based Med, 7, 735 Jia, 2020, Assessment of language bias and indexing bias among Chinese-sponsored randomized controlled trials, JAMA Netw Open, 3, e205894, 10.1001/jamanetworkopen.2020.5894 Normile, 2003, The new face of traditional Chinese medicine, Science, 299, 188, 10.1126/science.299.5604.188